Crossmark

Retrospective case–control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer

Crossref DOI link: https://doi.org/10.1007/s11604-023-01517-9

Published Online: 2024-01-12

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Watanabe, Ken https://orcid.org/0000-0002-4328-5662
Igarashi, Takao

Uchiyama, Mayuki

Ishigaki, Takayuki

Ojiri, Hiroya
License Information

Text and Data Mining valid from 2024-01-12

Version of Record valid from 2024-01-12
More Information

Article History

Received: 21 August 2023

Accepted: 18 November 2023

First Online: 12 January 2024

Declarations

:

: The authors declare that they have no competing interest.

: This study was approved by the Institutional Review Board ([approval number 33–432 (11057)]).

: The need for informed consent was waived due to the retrospective nature of this study.

Document is current

Any future updates will be listed below